About the Authors

Maria Rajecki

Contributed equally to this work with: Maria Rajecki, Mirkka Sarparanta

Affiliations Cancer Gene Therapy Group, Molecular Cancer Biology Program, Haartman Institute, Transplantation Laboratory and Finnish Institute for Molecular Medicine, University of Helsinki, Helsinki, Finland, HUSLAB, Helsinki University Central Hospital, Helsinki, Finland

Mirkka Sarparanta

Contributed equally to this work with: Maria Rajecki, Mirkka Sarparanta

Affiliation Laboratory of Radiochemistry, University of Helsinki, Helsinki, Finland

Tanja Hakkarainen

Affiliations Cancer Gene Therapy Group, Molecular Cancer Biology Program, Haartman Institute, Transplantation Laboratory and Finnish Institute for Molecular Medicine, University of Helsinki, Helsinki, Finland, HUSLAB, Helsinki University Central Hospital, Helsinki, Finland

Mikko Tenhunen

Affiliation Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland

Iulia Diaconu

Affiliations Cancer Gene Therapy Group, Molecular Cancer Biology Program, Haartman Institute, Transplantation Laboratory and Finnish Institute for Molecular Medicine, University of Helsinki, Helsinki, Finland, HUSLAB, Helsinki University Central Hospital, Helsinki, Finland

Venla Kuhmonen

Affiliation Laboratory of Radiochemistry, University of Helsinki, Helsinki, Finland

Kalevi Kairemo

Affiliations Department of Oncology, Helsinki University Central Hospital, Helsinki, Finland, International Comprehensive Cancer Center Docrates, Helsinki, Finland

Anna Kanerva

Affiliations Cancer Gene Therapy Group, Molecular Cancer Biology Program, Haartman Institute, Transplantation Laboratory and Finnish Institute for Molecular Medicine, University of Helsinki, Helsinki, Finland, HUSLAB, Helsinki University Central Hospital, Helsinki, Finland, Department of Obstetrics and Gynecology, Helsinki University Central Hospital, Helsinki, Finland

Anu J. Airaksinen

Affiliation Laboratory of Radiochemistry, University of Helsinki, Helsinki, Finland

Akseli Hemminki

akseli.hemminki@helsinki.fi

Affiliations Cancer Gene Therapy Group, Molecular Cancer Biology Program, Haartman Institute, Transplantation Laboratory and Finnish Institute for Molecular Medicine, University of Helsinki, Helsinki, Finland, HUSLAB, Helsinki University Central Hospital, Helsinki, Finland

Competing Interests

A. Hemminki is a co-founder and shareholder in Oncos Therapeutics ltd. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. There are no patents, products in development or marketed products to declare.

Author Contributions

Conceived and designed the experiments: MR MS TH MT KK AJA. Performed the experiments: MR MS TH MT KK AJA ID VK. Analyzed the data: MR MS TH MT KK AJA. Wrote the paper: MR MS TH MT AK AJA AH.